// App-Quantinova.ai

: Comparison of outcomes in augmentation naïve and augmented patients with alpha-1 antitrypsin deficiency related lung disease

Researchers

Presenter

  • Paul Ellis

Principal Investigators

  • Kristen Holm

  • Radmila Choate

  • David Mannino

  • Robert Stockley

  • Robert Sandhaus

  • Alice Turner

Medical Centers

  • Institute of Child Health, University of Birmingham, Birmingham, United Kingdom

  • Division of Medical, Behavioral, and Community Health, National Jewish Health, Denver, United States of America

  • Department of Preventive Medicine and Environmental Health, University of Kentucky College of Public Health, Lexington, United States of America

  • Lung Investigation Unit Medicine - University Hospitals Birmingham NHS Foundation Trust Queen Elizabeth Hospital Birmingham, UK, Birmingham, United Kingdom

  • Pulmonary, Critical Care and Sleep Medicine, National Jewish Health, Denver, CO, United States,

Locations

  • United Kingdom

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Genetic Disorder

  • Gastroenterology (GU)

  • Pulmonary/Respiratory Diseases

Disease

  • Alpha-1 antitrypsin (A1AT) deficiency

Biomarkers

  • Alpha-1 antitrypsin

Drug/Treatment

  • Alpha 1-Antitrypsin

Outcome

  • N/A

Study Design

  • Randomized

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved